Avecho Biotechnology Ltd News

Avecho Biotechnology Ltd: September 2024 Quarterly Activities Report & Appendix 4C

Oct 28 18:34 ET

Avecho Biotechnology Ltd: Appendix 4D and Half-year Financial Report

Aug 25 21:22 ET

Avecho Biotechnology Ltd: June 2024 Quarterly Activities Report & Appendix 4C

Jul 29 20:43 ET

Avecho Biotechnology Ltd: Receipt of R&D Tax Incentive

Jun 12 19:26 ET

Avecho Biotechnology Ltd: 2024 Annual General Meeting Results

May 30 01:29 ET

Avecho Biotechnology Ltd: Chair's Address and CEO Presentation

May 29 22:37 ET

Avecho Biotechnology Ltd: Notification of cessation of securities - AVE

May 20 20:48 ET

Avecho Biotechnology Ltd: First Patient dosed in Phase III insomnia trial

May 15 19:09 ET

Avecho Biotechnology Ltd: March 2024 Quarterly Activities Report & Appendix 4C

Apr 29 19:53 ET

Avecho Biotechnology Ltd: Initial Director's Interest Notice

Apr 25 21:49 ET

Avecho Biotechnology Ltd: Notice of Annual General Meeting/Proxy Form

Apr 25 19:55 ET

Avecho Biotechnology Ltd: Notification regarding unquoted securities - AVE

Apr 25 19:48 ET

Avecho Biotechnology Ltd: Appointment of New Director

Apr 25 19:34 ET

Avecho Biotechnology Ltd: Monash Sleep Health Symposium

Apr 21 19:23 ET

Avecho Biotechnology Ltd: Avecho commences Phase III insomnia trial

Mar 25 17:31 ET

Avecho Biotechnology Ltd: Avecho to present at NWR Virtual Healthcare Conference

Mar 17 18:24 ET

Avecho Biotechnology Ltd: Avecho meets TGA ahead of Phase III Clinical Trial

Mar 13 19:25 ET

Avecho Biotechnology Ltd: AVE receives final ethics approval for Phase III CBD trial

Mar 6 17:31 ET

Avecho Biotechnology Ltd: Appendix 4G and Corporate Governance Statement

Feb 29 01:42 ET

Avecho Biotechnology Ltd: Appendix 4E and Annual Report 31 December 2023

Feb 29 01:34 ET